A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer

作者全名："Xiao, Lei; Chen, Naifei; Pu, Chengfei; Zhao, Lingling; Li, Ning; Wang, Chang; Huang, Yusheng; Luo, Su-xia; Li, Xun; Yang, Zhenzhou; Bie, Jun; Zhu, Ruihong; Liang, Tingting; Wang, Yizhuo; Jia, Beibei; Chen, Dongqi; Wu, Zhao; Song, Yongping; Lu, Victor; Cui, Jiuwei"

作者地址："Innovat Cellular Therapeut Co Ltd, Rockville, MD USA; First Hosp Jilin Univ, Stem Cell & Canc Ctr, Changchun, Peoples R China; Innovat Cellular Therapeut Co Ltd, Shanghai, Peoples R China; Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China; Henan Canc Hosp, Zhengzhou, Peoples R China; Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Dept Canc Ctr, Chongqing, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Southwest Canc, Chongqing, Peoples R China; Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Ctr Canc, Chongqing, Peoples R China; Nanchong Cent Hosp, Nanchong, Peoples R China; Innovat Cellular Therapeut, Shanghai, Peoples R China; First Hosp Jilin Univ, Canc Ctr, Dept Oncol, Changchun, Peoples R China"

通信作者：　

来源：JOURNAL OF CLINICAL ONCOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001053772000751

JCR分区：Q1

影响因子：42.1

年份：2023

卷号：41

期号：16

开始页：　

结束页：　

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构：Innovative Cellular Therapeutics

基金资助正文：Innovative Cellular Therapeutics.